Color additives used in drug products must conform to FDA regulations and be properly listed and approved for the specific use. While a qualitative or quantitative change in inactive ingredients is ...
FDA’s draft guidance outlines a flexible approach that, under certain circumstances, allows applicants and manufacturers to replace a color additive in an approved or marketed drug product with one ...
Industry groups representing drugmakers have expressed support for a US Food and Drug Administration’s (FDA) draft guidance that would make it easier to replace color additives in drugs, though they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results